Dr. Mower helped invent an automatic implantable defibrillator, which corrects a patient’s inefficient heartbeat with an electric shock to resume its regular rhythm.
The FDA approved the technology in 1985, and it was eventually sold to pharmaceutical company Eli Lilly. Dr. Mower then became the company’s director of medical research.
Dr. Mower attended Johns Hopkins and the University of Maryland School of Medicine. He served as chief of cardiology at Sinai Hospital for several years.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
